Aida Cuenca‐Royo

Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial

Rafael de la Torre, Susana Solá, Gimena Hernández et al. · The Lancet Neurology · 2016 · 274 citations · Full text

Down Syndrome, Intellectual Impairment, Young Adults +7

Epigallocatechin‐3‐gallate, a DYRK1A inhibitor, rescues cognitive deficits in <scp>D</scp>own syndrome mouse models and in humans

Rafael de la Torre, Susana Solá, Meritxell Pons‐Espinal et al. · Molecular Nutrition & Food Research · 2013 · 270 citations

Type 2 diabetes and cognitive impairment in an older population with overweight or obesity and metabolic syndrome: baseline cross-sectional analysis of the PREDIMED-plus study

Núria Mallorquí‐Bagué, María Lozano‐Madrid, Estefanía Toledo et al. · Scientific Reports · 2018 · 100 citations · Full text

Psychometric properties of the CAST and SDS scales in young adult cannabis users

Aida Cuenca‐Royo, Albert Sánchez‐Niubò, Carlos G. Forero et al. · Addictive Behaviors · 2012 · 97 citations

Cannabis Use, Substance Abuse, Psychometric Properties +12

Physical fitness and physical activity association with cognitive function and quality of life: baseline cross-sectional analysis of the PREDIMED-Plus trial

Lidia Daimiel, Miguel Ángel Martínez‐González, Dolores Corella et al. · Scientific Reports · 2020 · 65 citations · Full text